Product Data Sheet

Sapacitabine (CYC682)

Catalog No. A12801

main product photo
Sapacitabine is an orally bioavailable pyrimidine analogue prodrug with potential antineoplastic activity.
Adooq's Sapacitabine (CYC682) has been cited by 1 publications
  • Sally L George, .et al. , EBioMedicine, 2020, Aug 23;59:102971 PMID: 32846370
  • Chemical Information
    Catalog NumA12801
    M. Wt490.63
    FormulaC26H42N4O5
    Purity>98%
    Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
    CAS No.151823-14-2
    SynonymsCYC 682, CYC-682, CS-682, CS682, CS 682
    SMILESCCCCCCCCCCCCCCCC(=O)NC1=NC(=O)N(C=C1)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)C#N
    Biological Activity
    DescriptionSapacitabine is an orally bioavailable pyrimidine analogue prodrug with potential antineoplastic activity.
    RETURN POLICY
    Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
    SHIPPING AND STORAGE
    Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.